New Generations Free of HIV, Syphilis, Hepatitis B, and Chagas Disease in the Americas. EMTCT Plus 2018; 2019


This document reports the progress made in the Americas towards the EMTCT of HIV and syphilis between 2010 and 2017. It is the first Regional report regarding elimination of mother-to-child and early childhood transmission of hepatitis B and congenital Chagas disease.

The main findings are as follows:

  • Access to prenatal and delivery care for pregnant women is high in the Americas.
  • Screening of pregnant women for HIV and syphilis remains high but little progress has been made in closing the gaps; meanwhile, screening of pregnant women for Chagas disease varies widely, ranging from 7% to 55% among the few reporting countries.
  • HIV and syphilis treatment of seropositive pregnant women continues to increase.
  • Vaccination for hepatitis B has stabilized at 87% of children under one year old who completed their third dose, and policies for universal timely hepatitis B vaccine birth dose are increasingly being adopted.
  • MTCT of HIV experienced longstanding reductions but has begun to stabilize.
  • Congenital syphilis cases are on the rise. Mother-to-child transmission is estimated to cause over 20% of new cases of Chagas disease.